CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, a PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Medical Immunology (Russia) - Russian Federation
doi 10.15789/1563-0625-2017-2-165-174
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SPb RAACI


Related search